Article
Antitumor capacity of a dominant-negative RET proto-oncogene mutant in a medullary thyroid carcinoma model.
Human gene therapy - 1 Jul 2003
Drosten M, Stiewe T, Pützer B M
Abstract excerpt
Gain-of-function mutations in the RET proto-oncogene resulting in a constitutively active receptor tyrosine kinase have been identified as responsible for three subtypes of multiple endocrine neoplasia type 2 (MEN-2) and the development of sporadic medullary and papillary thyroid carcinoma. An important strategy in cancer gene therapy is the inhibition of oncogenic signal transduction by interfering with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
